BRIEF-60 Degrees Pharmaceuticals, Inc. Announces Approval Of Reverse Stock Split Ratio

Reuters01-15

BRIEF-<a href="https://laohu8.com/S/SXTPW">60 Degrees</a> Pharmaceuticals, Inc. Announces Approval Of Reverse Stock Split Ratio

Jan 15 (Reuters) - 60 Degrees Pharmaceuticals Inc SXTP.O:

60 DEGREES PHARMACEUTICALS, INC. ANNOUNCES APPROVAL OF REVERSE STOCK SPLIT RATIO
60 DEGREES PHARMACEUTICALS INC - PHARMA ANNOUNCES 1:4 REVERSE STOCK SPLIT

Source text: ID:nGNX2xys4v

Further company coverage: SXTP.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2603600256?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-15 21:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2603600256","market":"fut","top_or_hot":-1,"title":"BRIEF-60 Degrees Pharmaceuticals, Inc. Announces Approval Of Reverse Stock Split Ratio","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/SXTPW\">60 Degrees</a> Pharmaceuticals, Inc. Announces Approval Of Reverse Stock Split Ratio</title></head><body><p><span>Jan 15 (Reuters)</span><span> - </span>60 Degrees Pharmaceuticals Inc <span>SXTP.O</span>:</p><ul><li><p>60 DEGREES PHARMACEUTICALS, INC. ANNOUNCES APPROVAL OF REVERSE STOCK SPLIT RATIO</p></li><li><p>60 DEGREES PHARMACEUTICALS INC - PHARMA ANNOUNCES 1:4 REVERSE STOCK SPLIT</p></li></ul><p>Source text: <span>ID:nGNX2xys4v</span></p><p>Further company coverage: <span>SXTP.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-60 Degrees Pharmaceuticals, Inc. Announces Approval Of Reverse Stock Split Ratio</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-60 Degrees Pharmaceuticals, Inc. Announces Approval Of Reverse Stock Split Ratio\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-01-15 21:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/SXTPW\">60 Degrees</a> Pharmaceuticals, Inc. Announces Approval Of Reverse Stock Split Ratio</title></head><body><p><span>Jan 15 (Reuters)</span><span> - </span>60 Degrees Pharmaceuticals Inc <span>SXTP.O</span>:</p><ul><li><p>60 DEGREES PHARMACEUTICALS, INC. ANNOUNCES APPROVAL OF REVERSE STOCK SPLIT RATIO</p></li><li><p>60 DEGREES PHARMACEUTICALS INC - PHARMA ANNOUNCES 1:4 REVERSE STOCK SPLIT</p></li></ul><p>Source text: <span>ID:nGNX2xys4v</span></p><p>Further company coverage: <span>SXTP.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SXTP","symbol_name":"60 degrees pharmaceuticals, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nTUACXQ3Y:1","article_id":"2603600256","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2603600256","pubTimestamp":1768482714,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-60 Degrees Pharmaceuticals, Inc. Announces Approval Of Reverse Stock Split RatioJan 15 (Reuters) - 60 Degrees Pharmaceuticals Inc SXTP.O:60 DEGREES PHARMACEUTICALS, INC. ANNOUNCES APPROVAL OF RE","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SXTP":"60 degrees pharmaceuticals, Inc.","BK4007":"制药","SXTPW":"60 Degrees Pharmaceuticals Equity Warrants Exp 16 May 2028 Warrant"},"translate_title":"简介-60 Degrees Pharmaceuticals，Inc.宣布批准反向股票分割比率","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SXTP":0.9,"SXTPW":0.9},"content_text":"BRIEF-60 Degrees Pharmaceuticals, Inc. Announces Approval Of Reverse Stock Split RatioJan 15 (Reuters) - 60 Degrees Pharmaceuticals Inc SXTP.O:60 DEGREES PHARMACEUTICALS, INC. ANNOUNCES APPROVAL OF REVERSE STOCK SPLIT RATIO60 DEGREES PHARMACEUTICALS INC - PHARMA ANNOUNCES 1:4 REVERSE STOCK SPLITSource text: ID:nGNX2xys4vFurther company coverage: SXTP.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2603600256","isCrawlerRequest":true}